In this regard, when a CRC metastasis is detected, it is recommended to carry out an immunohistochemical study, including detection of the mismatch repair deficiency (dMMR) and evaluation of HER2 status, as well as a molecular genetic study, and compare the results with the available data on the primary tumor [60,61]. The gene discussed is ERBB2; the disease is neoplasm.